ESTRATRIENE DERIVATIVES AND THEIR USES AS 17BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS

This invention relates to novel estratrien-triazoles of general formula (I) useful in therapy, especially for use in the treatment and/or prevention of a steroid hormone dependent disorder, preferably a steroid hormone dependent disease or disorder requiring the inhibition of a 17ß-hydroxysteroid de...

Full description

Saved in:
Bibliographic Details
Main Authors JOSEF MESSINGER, PASI KOSKIMIES, LILA KALLIO, UWE SCHOEN, BETTINA HUSEN, HEINRICH-HUBERT THOLE H
Format Patent
LanguageEnglish
Published 28.06.2013
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
STEROIDS
Online AccessGet full text

Cover

More Information
Summary:This invention relates to novel estratrien-triazoles of general formula (I) useful in therapy, especially for use in the treatment and/or prevention of a steroid hormone dependent disorder, preferably a steroid hormone dependent disease or disorder requiring the inhibition of a 17ß-hydroxysteroid dehydrogenase (17ß-HSD) such as 17ß-HSD type 1, type 2 or type 3 enzyme.
Bibliography:Application Number: HK20090109130